-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-tables1-5.pdf
June 02, 2025 - Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Seizure: Tables 1 - 5
Table 1 [=IMG1]: Codes to Identify Neuroimaging in Administrative Claims
Imaging Modality
Code Type
Codes
Computerized
Tomography (CT) of
Brain/Head
Revenue (U…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-tables11-12.pdf
June 02, 2025 - Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Seizure: Tables 11 & 12
Table 11. Mean (Standard Deviation) Proportion in Racial Groups within Sampled ZIP Codes of Residence‡
Sampled Group
Description
American
Indian or
Alask…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-tables7-10.pdf
January 01, 2006 - Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Seizure: Table 7 - 10
Table 7: Ratio of All MRI to All CT Scans within 30 days of Evaluation for Atraumatic Seizure Among Eligible
Children In Seven States – MAX Data
State
Ratio Component…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/depression/chipra-246-section-6.pdf
January 01, 2014 - Depression Care for Adolescents and Adults 2014 Testing Report
Depression Care for Adolescents and Adults
2014 Testing Report
Executive Summary
This report summarizes findings from quantitative testing conducted in 2014 to evaluate the feasibility and
variation in performance at the health plan level for t…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-scd-pain-specifications.pdf
June 02, 2025 - Sickle Cell Disease Measure 16: Appropriate Emergency Department Pain Assessment for Children With Sickle Cell Disease
1
Sickle Cell Disease
Measure 16: Appropriate Emergency Department Pain Assessment for Children with
Sickle Cell Disease
Description
The percentage of children identified as having S…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-7-e.pdf
June 02, 2025 - Section 7E
Table 12: Analyses of Differences in Inpatient Pediatric Experience Based on Respondent
Preferred Language
UNADJUSTED ANALYSIS
English
(12001)
Spanish
(1018) P-Value
Nurse-parent communication 80.8% 81.4% .57
Doctor-parent communication 82.2% 83.3% .27
Communication about medicines 79.9…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-6-b.pdf
June 02, 2025 - Section 6B
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-6-a.pdf
June 02, 2025 - Section 6A
Equation 1: Hospital-Level Unit Reliability
To calculate hospital-level unit reliability, we used the fo…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-section-6-b.pdf
June 02, 2025 - Section 6.B, Validity Tables
VI.B. Validity - Tables
Table 1. Multiple Concurrent Antipsychotic Use and Behavioral Health Hospita…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-7-a.pdf
June 02, 2025 - Section 7A
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-7-c.pdf
June 02, 2025 - Section 7C
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-7-d.pdf
June 02, 2025 - Section 7D
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-7-b.pdf
June 02, 2025 - Section 7B
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-section-1.pdf
June 02, 2025 - Section 1, SAS code
Duration of First Observed Enrollment
options mprint;
libname in '/PQMP/sas/ludwig/all_states/data';
data ps_a…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-section-2-specs.pdf
June 30, 2009 - Section 2, Detailed Measure Specifications
SECTION II.
DETAILED MEASURE SPECIFICATIONS:
INFORMED COVERAGE
II.A. Description
The percentage of time, within an 18-month observation window, eligible children received
coverag…
-
www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/finalsummary/finalsummary6.html
September 01, 2015 - Key Lessons from the National Evaluation of the CHIPRA Quality Demonstration Grant Program
Building … Previous Page Next Page
Table of Contents
Key Lessons from the National Evaluation of the CHIPRA
-
www.ahrq.gov/policymakers/chipra/overview/background/next-steps3.html
December 01, 2009 - Return to Contents
Family Experiences of Care
The CHIPRA legislation explicitly asked for core … Return to Contents
Availability of Services
CHIPRA directed the Secretary to include measures of
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-131-section-7-a-table-10-11-12.pdf
January 01, 2008 - Section 7-A, Tables 10, 11, and 12
Table 10 – Analysis of Disparities in Readmission Risk Based on Race/Ethnicity
2005-2009 AHRQ Revisit data for New Yo…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-8-table-7-8-9.pdf
October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1, Section 8, Tables 7, 8, and 9
Q-METRIC Sickle Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle
Cell Disease
Graphics for Section VIII Feasibility
VIII.A. Data Availability
TABLE 7: Summary o…
-
www.ahrq.gov/policymakers/chipra/overview/background/appendix-a6.html
December 01, 2009 - Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs
Background Report on request for public comment on initial, recommended core set of Children's Healthcare Quality Measures for voluntary…